Surge
Verticals:
deadline
TBD 2026
FEE:
Duration:
Next Deadline:
Next cohort intake:
Next Location:
Capital and operational muscle to scale.
Surge is where we invest in companies and embed operational expertise to drive them toward pre-clinical commercial readiness.
This is not just a funding round—it’s the inflection point where ventures become companies of consequence.
Here, capital meets execution.
Eligibility
What we offer
Streams
Outbound Ventures:
Inbound Ventures:
Who it’s for:
- Ventures with a validated business model, clear milestones, and proof-of-concept data.
- Companies preparing for clinical development or commercial expansion.
What happens:
- 8-12 month semi-residency, two cohorts per year.
- 4 startups per intake, receiving pre-seed/seed investment from Panacea Ventures.
- Embedded support across business development, hiring, corporate governance, and market access.
Key Outcomes
- Deliver pre-clinical commercial readiness or early market traction.
- Build the operational systems for scaling.
- Access downstream investors and strategic acquirers.
[apply now]
